BioPorto A/S (THOXF)
OTCMKTS
· Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024
BioPorto Revenue
In the year 2024, BioPorto had annual revenue of 36.24M DKK with 17.07% growth. BioPorto had revenue of 7.90M in the quarter ending December 31, 2024, with 20.38% growth.
Revenue
36.24M DKK
Revenue Growth
+17.07%
P/S Ratio
20.67
Revenue / Employee
755.06K DKK
Employees
48
Market Cap
103.98M USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.24M | 5.29M | 17.07% |
| Dec 31, 2023 | 30.96M | 1.99M | 6.87% |
| Dec 31, 2022 | 28.97M | 4.72M | 19.44% |
| Dec 31, 2021 | 24.25M | 1.05M | 4.53% |
| Dec 31, 2020 | 23.20M | -3.42M | -12.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
BioPorto News
- 5 weeks ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 5 weeks ago - BioPorto announces the Annual Report for 2024 - GlobeNewsWire
- 5 weeks ago - BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 - GlobeNewsWire
- 7 weeks ago - BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates - GlobeNewsWire
- 2 months ago - Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations - GlobeNewsWire
- 3 months ago - BioPorto A/S appoints new interim Chairman of the Board - GlobeNewsWire
- 3 months ago - BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals - GlobeNewsWire
- 4 months ago - BioPorto commences process to appoint new Chair of the Board of Directors - GlobeNewsWire